HIM
ABMD

Hermes Investment Management’s Abiomed Inc ABMD Stock Holding History

Hermes Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$40.2M Sell
98,309
-39,210
-29% -$14.2M 0.53% 68
2018
Q1 		$40M Sell
137,519
-3,776
-3% -$957K 0.58% 61
2017
Q4 		$26.5M Buy
141,295
+7,272
+5% +$1.36M 0.38% 95
2017
Q3 		$22.6M Buy
+134,023
New +$20.3M 0.34% 102

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hermes Investment Management's ABMD Position: Q2 2018 in Review

Hermes Investment Management reduced its Abiomed Inc (ABMD) stake by 29% in Q2 2018, selling an estimated $14.2M and leaving 98,309 shares worth $40.2M. The position accounts for 0.53% of the portfolio, ranked #68.

Hermes Investment Management first reported a position in ABMD in Q3 2017 and has held it in 4 quarters since. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

  • Hermes Investment Management held 98,309 shares of Abiomed Inc worth $40.2M as of Q2 2018.
  • Hermes Investment Management sold 39,210 Abiomed Inc shares in Q2 2018, an estimated $14.2M.
  • Abiomed Inc made up 0.53% of Hermes Investment Management's portfolio in Q2 2018, its #68 holding.
  • Hermes Investment Management first reported a position in Abiomed Inc in Q3 2017 and has held it in 4 quarters since.
  • 527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.